Gong, Y., Yang, L., Tang, J., Zheng, J., Witman, N., Jakob, P., Tan, Y., Liu, M., Chen, Y., Wang, H., & Fu, W
[11] Long-term metformin therapy reduces calcium-dependent intrinsic-factor binding, lowering B12 absorption and potentially necessitating higher or more frequent parenteral doses
Compound Specifications CAS 86168-78-7 MW 3357.93 g/mol Formula C149H246N44O42S Purity 99.213% Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning
doi: 10.1007/s11892-022-01453-4 31 HanBWangYLiHSunXZhouJYuX
Debunking the myth: Broader application: While GLP-1 agonists were originally developed for the treatment of type 2 diabetes, their benefits extend beyond blood sugar control
Plasma Processes Polym